An NHS trust has been fined £300,000 after admitting to failing to provide safe care to Chris Elliot, 59, who died from a pseudomonas aeruginosa infection contracted from a contaminated hospital shower while undergoing chemotherapy for leukaemia at Cheltenham General Hospital.
Taiwan's Insurance Bureau has excluded home cancer chemotherapy from new in-home acute care insurance due to a lack of statistical data on its incidence. Current policies only cover pneumonia, urinary tract infections, and soft tissue infections. Insurers will use data from these three conditions to develop future policies for home cancer treatment.
Taiwan's Health Minister Shiu-Chung Liang is urging insurance companies to update policies to cover home-based cancer chemotherapy. Many existing policies require hospitalization for claims, hindering the adoption of more cost-effective and patient-friendly home care models, which can halve medical costs.
Taiwan's Ministry of Health and Welfare (MOHW) plans to discuss with the Financial Supervisory Commission and insurers to adjust cancer insurance policies. The goal is to enable coverage for home-based chemotherapy and other new care models, as current policies often require hospitalization, leading to unnecessary bed occupancy.
Taiwan's Ministry of Health and Welfare and the Financial Supervisory Commission are working to enable home-based chemotherapy for cancer patients, addressing insurance coverage issues to allow treatment outside hospitals by the second half of the year.
NHS England has approved mirvetuximab soravtansine (Elahere) for women with platinum-resistant ovarian cancer, marking the first new drug for this condition in over 20 years. The treatment, administered every three weeks, delayed cancer progression and prolonged survival by an average of four months in clinical trials.
Cancer claims 10 million lives annually, with varying deadliness. New drugs show promise for pancreatic and head/neck cancers, and precision medicine is advancing. However, a global shortfall of 100 million healthcare workers by 2050 and treatment delays are critical issues. Worryingly, cancer rates are rising in those under 50, linked to environmental factors.
A new DNA test, Prosigna, can identify breast cancer patients who may not need chemotherapy, with a trial showing over two-thirds of participants could be treated with hormone therapy alone, yielding a 93.7% five-year survival rate.
A reader seeks advice on how to deal with a new colleague who may be a habitual liar, drawing parallels to a past experience and consulting with a psychologist.
The Bearded Baker in Houston was burglarized early Thursday, the day after owner Allan Hursig began chemotherapy for Stage 4 colon cancer. Three suspects broke in, causing damage but stealing only minor items. This is the third time the bakery has been targeted.
Pat Gentile, diagnosed with breast cancer, felt self-conscious after losing her hair. A stranger's compliment at a convenience store gave her courage. She credits the kindness as a turning point.
Exclusive: Sperm re-transplant offers hope that boys left infertile by chemotherapy could have biological children one dayIn a groundbreaking fertility trial, a man whose testicular tissue was frozen before he underwent chemotherapy as a child to be re-transplanted 16 years later has been able to produce sperm.It is the first time a transplant of cryopreserved prepubertal testicular tissue has been demonstrated to restore sperm production in an adult patient. The 27-year-old man had the sample frozen when he was 10, before undergoing potent chemotherapy as part of treatment for sickle cell disease. Continue reading...
A 24-year-old cancer patient in Foshan, China, sparked a viral relay of kindness after ordering companionship through a food delivery app on April 15. Little Li, battling rare blood cancer, asked a rider to sit by her bedside for two hours, highlighting her loneliness during treatment with her father working away to fund her care.
Aarav Vats, a student at Amity International School, Saket, achieved a 96.6% score in his CBSE Class 10 board exams while undergoing treatment for lymphoblastic lymphoma. His story highlights the importance of support systems and a balanced approach to success.
The NHS is expanding genetic testing for cancer patients to include a fifth DPYD gene variant, more prevalent in Black and minority ethnic individuals, aiming to prevent severe chemotherapy side-effects and fatal reactions.
GSK has announced promising early-stage trial results for its cancer treatment Mo-Rez, which showed high efficacy in shrinking tumors for ovarian and endometrial cancer patients. The company plans to move directly to late-stage clinical trials.
